Laurion Capital Management’s Nuvation Bio NUVB Stock Holding History

Laurion Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$44.4M	Sell	7,820,013 -2,625	-0%	-$12.8K	1.14%	21
2026 Q1	$33.6M	Sell	7,822,638 -30,000	-0.4%	-$167K	1.46%	10
2025 Q4	$70.4M	Sell	7,852,638 -1,852,894	-19%	-$11.5M	2.62%	10
2025 Q3	$35.9M	Sell	9,705,532 -535,174	-5%	-$1.46M	0.62%	36
2025 Q2	$20M	Buy	10,240,706 +369,629	+4%	+$770K	0.36%	71
2025 Q1	$17.4M	Buy	9,871,077 +3,379,602	+52%	+$7.69M	0.44%	55
2024 Q4	$17.3M	Buy	6,491,475 +4,900,000	+308%	+$12.6M	0.32%	65
2024 Q3	$3.64M	Hold	1,591,475	–	–	0.05%	126
2024 Q2	$4.65M	Buy	+1,591,475	New	+$4.86M	0.06%	167
2022 Q3	–	Sell	-135,219	Closed	-$438K	–	573
2022 Q2	$438K	Sell	135,219 -304,547	-69%	-$1.33M	0.01%	347
2022 Q1	$2.31M	Buy	+439,766	New	+$2.47M	0.03%	201

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Laurion Capital Management's NUVB Position: Q2 2026 in Review

Laurion Capital Management reduced its Nuvation Bio (NUVB) stake by 0.03% in Q2 2026, selling an estimated $12.8K and leaving 7,820,013 shares worth $44.4M. The position accounts for 1.14% of the portfolio, ranked #21.

Laurion Capital Management first reported a position in NUVB in Q1 2022 and has held it in 11 quarters since. The position peaked at $70.4M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

Laurion Capital Management held 7,820,013 shares of Nuvation Bio worth $44.4M as of Q2 2026.
Laurion Capital Management sold 2,625 Nuvation Bio shares in Q2 2026, an estimated $12.8K.
Nuvation Bio made up 1.14% of Laurion Capital Management's portfolio in Q2 2026, its #21 holding.
Laurion Capital Management first reported a position in Nuvation Bio in Q1 2022 and has held it in 11 quarters since.
Laurion Capital Management's Nuvation Bio position peaked at $70.4M in Q4 2025.
244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Laurion Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.